Mylan Inc. (MYL) said its subsidiary Mylan Laboratories Ltd. received tentative approval from the U.S. Food and Drug Administration, or FDA, for its Abbreviated New Drug Application, or ANDA, for Atorvastatin Calcium Tablets, 10 mg (base), 20 mg (base), 40 mg (base) and 80 mg (base).
Atorvastatin Calcium is the generic equivalent to Pfizer's Lipitor Tablets, indicated for the prevention of cardiovascular disease and hypercholesterolemia.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.